Invitrogen™ ProcartaPlex™ Human Brain Injury Panel, 5plex

Ref.: BL-RE-159689Manufacturer ref.: EPX050-15838-901 96 dosages
€1,724.00 excl. VAT

The Human 5-Plex ProcartaPlex for Brain Injury panel allows neurological research by analyzing GFAP, NF-H, S100B, NSE, and UCHL1 protein targets in a single well using Luminex xMAP technology. Simultaneous detection of...

Product type
Multiplex panel
Quantity
96 dosages
Species
Human
Combinability
Not combinable
Type of microbead
Magnetic
Brand
Invitrogen

The Human 5-Plex ProcartaPlex for Brain Injury panel allows neurological research by analyzing GFAP, NF-H, S100B, NSE, and UCHL1 protein targets in a single well using Luminex xMAP technology. Simultaneous detection of...

The Human 5-Plex ProcartaPlex for Brain Injury panel allows neurological research by analyzing GFAP, NF-H, S100B, NSE, and UCHL1 protein targets in a single well using Luminex xMAP technology. Simultaneous detection of these targets, released due to astroglial injury (GFAP, S100B), axonal injury (NF-H) and neuronal cell injury (UCH-L1) may help to understand the progression of neurological disorders.

The panel is supplied in a ready-to-use format with individual vials of capture and detection reagents formulated at a concentration of 1X, requiring less pipeting and experimental configuration. It cannot be associated with simplexes or other panels. It completes the ProcartaPlex 6-Plex panel for neuroinflammation (ref. No. EPX060-15833-901) and the ProcartaPlex 9-Plex panel for neurodegeneration (ref. EPX090-15836-901) which provides 15 additional protein targets in the same research area. ProcartaPlex preconfigured panels are widely tested for combinability, interference and cross-reactivity of analyses to provide the highest level of validation and accuracy.

Target list [microbead region]: GFAP [22], NF-H [33], NSE [12], S100B [18], UCHL1 [19]

About ProcartaPlex strengths for Luminex platform

ProcartaPlex immunoassays, based on the principles of a sandwich ELISA, use two highly specific antibodies binding to different epitopes of a protein to simultaneously quantify all target proteins using a Luminex instrument. ProcartaPlex multiplex assays require only 25 µl plasma or serum, or 50 µl cell culture supernatant, and only four hours to obtain the analyzed results.

• Reproducible and reliable results — validated in panel to the highest industry standard, with tests for protein target combinationability and cross-reactivity

• Plus of results per sampler — allows multiple protein targets to be achieved simultaneously in a single sample of 25 - 50 µl

• High-reference multiplexing platform with well established Luminex technology for protein detection and quantification

ProcartaPlex assays use Luminex xMAP (multianalyte profiling) Technology for simultaneous detection and quantification of up to 80 protein targets in a single 25–50 µl sample — plasma, serum, cell culture supernatant and other body fluids.

Luminex microbeads in the ProcartaPlex assay are coloured internally with precise proportions of red fluorophores and IR to create unique spectral signatures that can be identified by Luminex xMAP detection systems (e.g. Luminex 200, FLEXMAP 3D and MAGPIX). Like ELISA sandwich, the ProcartaPlex assay uses paired antibody pairs to identify the protein of interest. In a multiplexed assay, each single spectral microbead is marked with antibodies specific to a single target protein and the bound proteins are identified with biotinyl antibodies and streptavidine–R-phycoerythrin (RPE). Conjugation of specific antibodies from a protein to a separate microbead makes it possible to analyze several targets in a single well.

The most significant difference between a ProcartaPlex assay and a ELISA assay is that the ProcartaPlex capture antibody is conjugated with a microbead and is not adsorbed by any of the microplate wells. Thus, ProcartaPlex dosing reagents float freely in the solution. For detection purposes, Luminex 200, for example, contains two lasers: one to distinguish the spectral signature from each microbead and one to quantify the amount of fluorescence of RPE. The latter is proportional to the amount of protein present in the sample. Multiplex ProcartaPlex assays can profile more target proteins using a significantly smaller sample. It takes them as long as they do a traditional ELISA sandwich.

Reproducibility

Intra-dose variation coefficient Less than 15%, inter-dose Less than 15%.

Species

Species: Human.

Samples

Sample type: Serum, plasma, cephalo-rachid fluid, Plasma, Cerebrospinal Fluid (Serum volume, plasma, CSF: 25 µlitres).

Compatibility

Designed for use with: Luminex Instruments.

ProcartaPlex™ range

It is part of the ProcartaPlex™ range.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17145003
Specifications
Product typeMultiplex panel
Quantity96 dosages
SpeciesHuman
CombinabilityNot combinable
Type of microbeadMagnetic
Microbead areaNSE [12], GFAP [22], PNF-H [33], UCHL-1 [19], S100b [18]
Sensitivity of the dosageSee Certificate of Analysis
Dose rangeSee Certificate of Analysis
FormatMultiplex kit
For use with (equipment)Luminex instruments
Coefficient of inter-dose variationLess than 15%
Coefficient of intra-dose variationLess than 15%
Product rangeProcartaPlex™
Type of sampleSerum, plasma, cerebrospinal fluid, Plasma, Cerebrospinal Fluid
Research AreaNeurobiology
Physical characteristics
Volume of sampleSerum, plasma, CSF: 25 µlitres
Storage and shipping
Content and storage• 2 vials of human standard 4 (lyophilized)
• 1 vial of capture microbeads (1X)
• 1 bottle of biotinyl antibody mixture (1X)
• 1 vial of reading pad (1X)
• 1 vial of Streptavidine-PE (1X)
• 1 vial of universal dosing buffer
Shipping conditionsMoist ice

Origin and customs

Manufacturer ref.EPX050-15838-901
Country of originAutriche
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.